UnitedHealth Q1 Earnings Beat, Shares Rise 5%

UnitedHealth posted Q1 adjusted EPS $7.23, beating $6.59 consensus, and revenue $111.7bn surpassing $109.44bn expectations.
Shares jumped over 5% in pre‑market trading, and the company forecast FY2026 adjusted EPS of at least $18.25, above $17.87 consensus.
UnitedHealth announced a $2 billion share repurchase program by end of Q2 and reported cash flow from operations of $8.9 billion (1.4× net income).
Optum units mixed: Rx $35.7bn (+2% YoY), Insight flat $5.1bn, Health down 3% to $24.1bn; net margin 5.6%, debt‑to‑capital 42.9%.